No Detail Found!

The therapeutic effects of Hexuetongbi formula to combat the oxaliplatin-induced peripheral neuropathy using network pharmacological methods in rat model

Author(s)
Jingyu Feng Department of Oncology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, Shenzhen 518133, China;The First School of Clinical Medicine, Guangzhou University of Traditional Chinese Medicine, Guangzhou 510405, Guangdong, China
Li Yang Department of Oncology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, Shenzhen 518133, China
Jiguo Wang Department of Oncology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, Shenzhen 518133, China;The First School of Clinical Medicine, Guangzhou University of Traditional Chinese Medicine, Guangzhou 510405, Guangdong, China
Jing Zhang Department of Oncology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, Shenzhen 518133, China;The First School of Clinical Medicine, Guangzhou University of Traditional Chinese Medicine, Guangzhou 510405, Guangdong, China
Lizhu Lin The First School of Clinical Medicine, Guangzhou University of Traditional Chinese Medicine, Guangzhou 510405, Guangdong, China; Department of Oncology, The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou 510405, Guangdong, China
Abstract
The objective of this study was to elucidate the mechanism of the Hexuetongbi formula in treating Chemotherapy-induced Peripheral Neuropathy (CIPN) using network pharmacology, pharmacodynamics, and mechanistic approaches in an oxaliplatin-induced peripheral neuropathy rat model. Network pharmacology is crucial for understanding the multi-target effects of the Hexuetongbi formula on CIPN. This approach allows for a comprehensive mapping of the complex interactions between the formula's constituents and the biological pathways involved in CIPN, revealing potential synergistic effects and enhancing the formula's pharmacological validation. The Hexue Tongbi formula's impact was analyzed on rats undergoing peripheral neuropathy, observing changes in the morphology of L4-6 dorsal root ganglion neurons through hematoxylin and eosin (HE) staining. Simultaneously, a network pharmacology approach was employed, utilizing TCMSP and GeneCards databases to identify common targets between CIPN and Hexue Tongbi's therapeutic entities. These core targets were scrutinized through GO enrichment and KEGG pathway analysis. To validate the findings, mRNA and protein expression levels in the L4-6 dorsal root ganglion were examined using quantitative PCR and Western Blot assays. Significant modifications were observed in the frequency of cold stimulus withdrawal reflexes and the L4-6 dorsal root ganglion neurons, while the mechanical withdrawal reflex threshold displayed a considerable decrease. In rats treated with the Hexuetongbi formula post-oxaliplatin, there was noteworthy mitigation in the cold stimulation paw withdrawal threshold and augmentation in the mechanical stimulation paw withdrawal threshold. Network pharmacology identified 19 active constituents in Hexuetongbi and 35 targets for CIPN, with the PI3K/Akt signaling pathway emerging as a prominent target. There was a significant upregulation in PI3K, Akt1, Akt2, and Bcl-2 compared to controls, suggesting that Hexuetongbi effectively mitigates oxaliplatin-induced peripheral neuropathy through the modulation of the PI3K/Akt and Bcl-2 pathways.
Publication Details
Page(s) 1-19
Published Journal: Asian Journal of Agriculture and Biology, Volume: 4, Issue: 0, Year: 2024

Request the full text from PASTIC

Keywords
Oxaliplatin, Dorsal Root Ganglion, Chemotherapy-induced peripheral neuropathy, traditional Chinese medicine, Apoptosis
References
Abbruzzese G,Morón-Oset J,Díaz-Castroverde S,García-Font N,Roncero C,López-Muñoz F,Oset-Gasque Marco Contelles JL,MJ Marco Contelles JL .2020 .Neuroprotection by phytoestrogens in the model of deprivation and resupply of oxygen and glucose in vitro: the contribution of autophagy and related signaling mechanisms. Antioxidants, 9 : 545.
Albers JW,Chaudhry V,Cavaletti G,Donehower RC .2014 .Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst. Rev. 3., : .
Argyriou AA .2015 .Updates on oxaliplatin-induced peripheral neurotoxicity (OXAIPN). Toxics, 3 : 187-197.
Argyriou AA,Bruna J,Marmiroli P,Cavaletti G .2012 .Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit. Rev. Oncol. Hematol, 82 : 51-77.
Argyriou AA,Polychronopoulos P,Iconomou G,Chroni E,Kalofonos HP .2008 .A review on oxaliplatin-induced peripheral nerve damage. Cancer Treat. Rev, 34 : 368-77.
Chen X,Sun W,Gianaris NG,Riley AM,Cummins TR,Fehrenbacher JC,Obukhov AG .2014 .Furanocoumarins are a novel class of modulators for the transient receptor potential vanilloid type 1 (TRPV1) channel. J. Biol. Chem, 289 : 9600-9610.
Delaunoit T,Alberts SR,Sargent DJ,Green E,Goldberg RM,Krook J,Fuchs C,Ramanathan RK,Williamson SK,Morton RF .2005 .Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. , 16 : 425-429.
Gamelin L,Boisdron-Celle M,Morel A,Poirier AL,Berger V,Gamelin E,Tournigand C,de Gramont A .2008 .Oxaliplatin-related neurotoxicity: interest of calcium-magnesium infusion and no impact on its efficacy. J. Clin. Oncol, 26 : 1188-1189.
Hao T,Rockwell P .2013 .Signaling through the vascular endothelial growth factor receptor VEGFR-2 protects hippocampal neurons from mitochondrial dysfunction and oxidative stress. Free Radic. Biol. Med, 63 : 421-431.
Heinemann V,Haas M,Boeck S .2012 .Systemic treatment of advanced pancreatic cancer. Cancer Treat. Rev, 38 : 843-853.
Hershman DL,Lacchetti C,Dworkin RH,Lavoie Smith EM,Bleeker J,Cavaletti G,Chauhan C,Gavin P,Lavino A,Lustberg MB .2014 .Prevention and management of chemotherapyinduced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J. Clin. Oncol, 32 : 1941-1967.
Hikino H and Murayama M .1985 .Mechanism of the antinociceptive action of mesaconitine: participation of brain stem and lumbar enlargement. Br. J. Pharmacol, 85 : 575-580.
Holmes J,Stanko J,Varchenko M,Ding H,Madden VJ,Bagnell CR,Wyrick SD,Chaney SG .1998 .Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model. Toxicol. Sci, 46 : 342-351.
Hochster HS .2007 .Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity. J. Clin. Oncol, 25 : 4028-4029.
Hwang SH,Choi YG,Jeong MY,Hong YM,Lee JH,Lim S .2009 .Microarray analysis of gene expression profile by treatment of Cinnamomi Ramulus in lipopolysaccharide-stimulated BV-2 cells. , 443 : 83-90.
Jasmin L,Kohan L,Franssen M,Janni G,Goff JR .1998 .The cold plate as a test of nociceptive. , : .
Jongen JLM,Broijl A,Sonneveld P .2015 .Chemotherapy-induced peripheral neuropathies in hematological malignancies. J. Neurooncol, 121 : 229-237.
Kang U,Han AR,So Y,Jin CH,Ryu SM,Lee D,Seo EK .2019 .Furanocoumarins from the Roots of Angelica dahurica with Inhibitory Activity against Intracellular Reactive Oxygen Species Accumulation. J. Nat. Prod, 82 : 2601-2607.
Lee MY,Lee JA,Seo CS,Ha H,Lee H,Son JK,Shin HK,Chem Food .2011 .Anti-inflammatory activity of Angelica dahurica ethanolic extract on RAW264. 7 cells via upregulation of heme oxygenase-1. , 49 : 1047-1055.
Limbourg FP,Huang Z,Plumier JC,Simoncini T,Fujioka M,Tuckermann J,Schütz G,Moskowitz MA,Liao JK .2003 .Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J. Clin. Invest, 111 : 759.
Liu H,Wang J,Zhou W,Wang Y,Yang L .2013 .Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice. J. Ethnopharmacol, 146 : 773-793.
Liu X,Ou K,Ma X,Gao L,Wang Q,Zhang H,Yang L .2022 .Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: a retrospective cohort study. BMC Cancer, 22 : 807.
Loprinzi CL,Lacchetti C,Bleeker J,Cavaletti G,Chauhan C,Hertz DL,Kelley MR,Lavino A,Lustberg MB,Paice JA,Schneider BP,Lavoie Smith EM,Smith ML,Smith TJ,WagnerJohnston N,Hershman DL .2020 .Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. J. Clin. Oncol, 38 : 3325-3348.
Loprinzi CL,Qin R,Dakhil SR,Fehrenbacher L,Flynn KA,Atherton P,Seisler D,Qamar R,Lewis GC,Grothey A .2014 .Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance). J. Clin. Oncol, 32 : 997.
Lu W,Giobbie‐Hurder A,Freedman RA,Shin IH,Lin NU,Partridge AH,Rosenthal DS,Ligibel JA .2020 .Acupuncture for ChemotherapyInduced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial. The Oncologist, 25 : 310-318.
Mannelli LDC,Zanardelli M,Failli P,Ghelardini C .2012 .Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin. J. Pain, 13 : 276-284.
Misawa S,Denda T,Kodama S,Suzuki T,Naito Y,Kogawa T,Takada M,Suichi T,Shiosakai K,Kuwabara S,Saito G,Hino A,Imanishi S,Ureshino N,Satomi D,Tanabe Y,Hanaoka Y,Miyamoto A,Suzuki T,Naganuma A,Yanagita Y,Sekine K,Kusano F,Nakamura M,Imazeki H .2023 .Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study). BMC Cancer, 23 : 1098.
Nara K,Yamamoto T,Yamashita H,Yagi K,Takada T,Seto Y,Suzuki H .2023 .Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab therapy: a single center retrospective study. BMC Cancer, 23 : 979.
Research National .2011 .Use of Laboratory Animals (Washington (DC): National Academies Press (US)). , : .
Nesterova YV,Povet'yeva TN,Suslov NI,Zyuz'kov GN,Pushkarskii SV,Aksinenko SG,Schultz EE,Kravtsova SS,Krapivin AV .2014 .Analgesic activity of diterpene alkaloids from Aconitum baikalensis. Bull. Exp. Biol. Med, 157 : 488.
Sasako M,Sakuramoto S,Katai H,Kinoshita T,Furukawa H,Yamaguchi T,Nashimoto A,Fujii M,Nakajima T,Ohashi Y .2011 .Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer. J. Clin. Oncol, 29 : 4387-4393.
Sayyah M,Valizadeh J,Kamalinejad M .2002 .Anticonvulsant activity of the leaf essential oil of Laurus nobilis against pentylenetetrazole-and maximal electroshock-induced seizures. Phytomedicine, 9 : 212-216.
Scuteri A,Galimberti A,Maggioni D,Ravasi M,Pasini S,Nicolini G,Bossi M,Miloso M,Cavaletti G,Tredici G .2009 .Role of MAPKs in platinum-induced neuronal apoptosis. Neurotoxicology, 30 : 312-319.
Sell AB,Carlini EA .1976 .Anesthetic action of methyleugenol and other eugenol derivatives. Pharmacology, 14 : 367-377.
Sisalli MJ,Secondo A,Esposito A,Valsecchi V,Savoia C,Di Renzo GF,Annunziato L,Scorziello A .2014 .Endoplasmic reticulum refilling and mitochondrial calcium extrusion promoted in neurons by NCX1 and NCX3 in ischemic preconditioning are determinant for neuroprotection. Cell Death Differ, 21 : 1142-1149.
Smith EML,Pang H,Cirrincione C,Fleishman S,Paskett ED,Ahles T,Bressler LR,Fadul CE,Knox C,Le-Lindqwister N,Gilman PB,Shapiro CL .2013 .Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA, 309 : 1359-1367.
Staff NP,Grisold A,Grisold W,Windebank A J .2017 .Chemotherapy‐induced peripheral neuropathy: a current review. Ann. Neurol, 81 : 772-781.
Suzuki Y,Oyama T,Ishige A,Isono T,Asami A,Ikeda Y,Noguchi M,Omiya Y .1994 .Antinociceptive mechanism of the Actonitine alkaloids mesaconitine and benzoylmesaconine. Planta Med, 60 : 391-394.
Wang KS,Lv Y,Wang Z,Ma J,Mi C,Li X,Xu GH,Piao LX,Zheng SZ,Jin X .2017 .Imperatorin efficiently blocks TNF-α-mediated activation of ROS/PI3K/Akt/NF-κB pathway. Oncol. Rep, 37 : 3397-3404.
Xiong J,Bui VB,Liu XH,Hong ZL,Yang GX,Hu JF .2014 .Lignans from the stems of Clematis armandii (“Chuan-Mu-Tong”) and their antineuroinflammatory activities. J. Ethnopharmacol, 153 : 737-743.
Yang H,Cheng X,Yang Y,Wang Y,Du G .1860 .Ramulus Cinnamomi extract attenuates neuroinflammatory responses via downregulating TLR4/MyD88 signaling pathway in BV2 cells. Neural Regen. Res, 12 : .
Yano S,Suzuki Y,Yuzurihara M,Kase Y,Takeda S,Watanabe S,Aburada M,Miyamoto K .2006 .Antinociceptive effect of methyleugenol on formalin-induced hyperalgesia in mice. Eur. J. Pharmacol, 553 : 99-103.
Zhao H,Mitchell S,Koumpa S,Cui YT,Lian Q,Hagberg H,Johnson MR,Takata M,Ma D .2016 .Heme oxygenase-1 mediates neuroprotection conferred by argon in combination with hypothermia in neonatal hypoxia-ischemia brain injury. Anesthesiology., : .
. .MOL005802 propyleneglycol monoleate. , : .
. .. MOL000953 CLR, : .
. .. , : .
. .. MOL001749 ZINC03860434, : .
. .. MOL003791 Linolein, : 2.
. .. MOL007514 methyl icosa-11, : 14-dienoate.
0

Citations

0

Downloads

12

Views